Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-25T08:58:11.896Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of Intranasal Mupirocin Prophylaxis on Methicillin-Resistant Staphylococcus aureus Transmission and Invasive Staphylococcal Infections in a Neonatal Intensive Care Unit

Published online by Cambridge University Press:  02 April 2018

Elizabeth H. Ristagno ,
Kristina A. Bryant ,
Lynette F. Boland ,
Gordon G. Stout ,
Alan D. Junkins ,
Charles R. Woods ,
John A. Myers  and
Claudia M. Espinosa
Elizabeth H. Ristagno
Affiliation:
Division of Pediatric Infectious Diseases, Mayo Clinic, Rochester, Minnesota
Kristina A. Bryant
Affiliation:
Department of Pediatrics, University of Louisville, Louisville, Kentucky
Lynette F. Boland
Affiliation:
Norton Children’s Hospital, Louisville, Kentucky
Gordon G. Stout
Affiliation:
Department of Pediatrics, University of Louisville, Louisville, Kentucky
Alan D. Junkins
Affiliation:
Norton Healthcare, Louisville, Kentucky
Charles R. Woods
Affiliation:
Department of Pediatrics, University of Louisville, Louisville, Kentucky
John A. Myers
Affiliation:
Department of Pediatrics, University of Louisville, Louisville, Kentucky
Claudia M. Espinosa*
Affiliation:
Department of Pediatrics, University of Louisville, Louisville, Kentucky
*
Address correspondence to Claudia M. Espinosa, MD, Department of Pediatrics, University of Louisville, 571 S Floyd St Suite 321, Louisville, Kentucky ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

The use of monthly intranasal mupirocin was associated with a significant reduction in the rate of methicillin-resistant Staphylococcus aureus transmission and Staphylococcus aureus invasive infection in a large neonatal intensive care unit. Resistance to mupirocin emerged over time, but it was rare and was not associated with adverse clinical outcomes.

Infect Control Hosp Epidemiol 2018;39:741–745

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 39 , Issue 6 , June 2018 , pp. 741 - 745
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION. Findings presented at the Infectious Diseases Society of America’s IDWeek on October 10, 2015, in San Diego, California, and at the Society for Healthcare Epidemiology of America (SHEA) meeting on May 20, 2016, in Atlanta, Georgia.

References

REFERENCES

1. Huang, YC. Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics 2006;118:469–474.Google Scholar
2. Lally, RT, Lanz, E, Schrock, C. G. Rapid control of an outbreak of Staphylococcus aureus on a neonatal intensive care department using standard infection control practices and nasal mupirocin. Am J Infect Control 2004;32:44–47.Google Scholar
3. Delaney, HM, Wang, E, Melish, M. Comprehensive strategy including prophylactic mupirocin to reduce Staphylococcus aureus colonization and infection in high-risk neonates. J Perinatol 2013;33:313–318.Google Scholar
4. Song, X, Cheung, S, Klontz, K, Short, B, Campos, J, Singh, N. A stepwise approach to control an outbreak and ongoing transmission of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Am J Infect Control 2010;38:607–611.Google Scholar
5. Antonov, NK, Garzon, MC, Morel, KD, Whittier, S, Planet, PJ, Lauren, CT. High prevalence of mupirocin resistance in Staphylococcus aureus isolates from a pediatric population. Antimicrob Agents Chemother 2015;59:3350–3356.Google Scholar
6. The Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 1996;7:2403–2408.Google Scholar
7. Cochrane Effective Practice and Organisation of Care Review Group (EPOC). Data collection checklist—Cochrane Effective Practice and Organisation of Care Review Group. EPOC website. http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/datacollectionchecklist.pdf. Updated 2002. Accessed August 11, 2016.Google Scholar
8. Suwantarat, N, Carroll, KC, Tekle, T, Ross, T, Popoola, VO, Milstone, AM. Low prevalence of mupirocin resistance among hospital-acquired methicillin-resistant Staphylococcus aureus isolates in a neonatal intensive care unit with an active surveillance cultures and decolonization program. Infect Control Hosp Epidemiol 2015;36:232–233.CrossRefGoogle Scholar
9. Park, S, Kim, SY, Lee, JH, Park, C, Lee, DG. Community-genotype strains of methicillin-resistant Staphylococcus aureus with high-level mupirocin resistance in a neonatal intensive care unit. Early Hum Dev 2013;89:661–665.Google Scholar
10. Pierce, R, Bryant, K, Lessler, J, Milstone, AM. Bacterial and fungal infections in neonates following mupirocin-based MRSA decolonization: a multicenter cohort study. Infect Control Hosp Epidemiol 2017;38:930–936.Google Scholar